Safety and Assessment of Breakthrough Therapies
- Charles River’s phototoxicity expert ensures drug safety in bright conditions
September 17, 2020
BY: Mary Parker
- Not every due diligence audit needs to be face-to-face
September 2, 2020
BY: Deanna Talerico
- In the world of regulatory toxicology, it’s all about finding the caveats
August 17, 2020
BY: Regina Kelder
- The pandemic has put a whole different spin on how we analyze slides remotely
July 2, 2020
BY: Aleksandra Zuraw
- Long-awaited study evaluates wide variability in the platforms and sites that use these ion channel assays  
June 16, 2020
BY: Regina Kelder
- Amy Smith’s varied career brings collaborative perspective to her work on COVID-19 research
May 26, 2020
BY: Mary Parker
- Emergency plan based on historic precedent
May 14, 2020
BY: Mary Parker
- The latest worrisome phenomenon in SARS-CoV-2 infection--changes in the blood clotting properties of patients
May 11, 2020
BY: Florence Poitout
- Coinciding with the urgent need for laboratory findings has been a slow-down and readjustment of life on the outside
May 4, 2020
BY: Regina Kelder
- Will alternative assays for developmental toxicity gain regulatory acceptance?
April 15, 2020
BY: Alan Hoberman